← All Sponsors
SPONSOR

Qilu Hospital of Shandong University

Total Trials
14
Recruiting
14
Phases
Phase 1, Phase 2, Phase 4, Phase 2

Qilu Hospital of Shandong University is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Cancer of Stomach, Adenocarcinoma, Ascites, Malignant, Carcinoma, Hepatocellular, Immunotherapy.

The trial portfolio spans Phase 1, Phase 2, Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Qilu Hospital of Shandong University

How many clinical trials has Qilu Hospital of Shandong University sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Qilu Hospital of Shandong University, of which 14 are actively recruiting participants. These trials cover conditions including Cancer of Stomach, Adenocarcinoma, Ascites, Malignant, Carcinoma, Hepatocellular. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qilu Hospital of Shandong University research focus on?
Qilu Hospital of Shandong University clinical trials span Cancer of Stomach, Adenocarcinoma, Ascites, Malignant, Carcinoma, Hepatocellular, Immunotherapy, Non ST Segment Elevation Acute Coronary Syndrome, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Qilu Hospital of Shandong University clinical trial?
To participate in a Qilu Hospital of Shandong University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qilu Hospital of Shandong University trials with current recruitment status updated daily.

Clinical Trials by Qilu Hospital of Shandong University

NCT06759064 Phase 1, Phase 2
Recruiting

Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites

Cancer of Stomach, Adenocarcinoma
NCT06571396
Recruiting

Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

Carcinoma, Hepatocellular
NCT06197724
Recruiting

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Non ST Segment Elevation Acute Coronary Syndrome
NCT05638503
Recruiting

Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension

Hypertension
NCT06279247
Recruiting

Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy

Narcolepsy
NCT07379255
Recruiting

Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

Bladder Cancer
NCT04728516 Phase 4
Recruiting

The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Acute Coronary Syndrome
NCT06702891
Recruiting

Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer

Gastric Cardia Cancer
NCT07546877
Recruiting

High-Frequency Repetitive Transcranial Magnetic Stimulation for Cognitive Improvement in Patients With Post-Stroke Cognitive Impairment

Post-Stroke Cognitive Impairment (PSCI)
NCT07495111
Recruiting

Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis

Cholelithiasis Associated With Common Bile Duct Stones
NCT06719037
Recruiting

Comparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal Stenosis

Lumbar Spinal Stenosis
NCT06092736 Phase 4
Recruiting

Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)

Microvascular Angina
NCT06327906
Recruiting

A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China

Child Allergy
NCT06735326 Phase 2
Recruiting

Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer

Ovarian Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology